Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Oct 27, 2021; 13(10): 1202-1215
Published online Oct 27, 2021. doi: 10.4240/wjgs.v13.i10.1202
Table 5 Multivariate analysis [Cox regression analysis (Enter method)] for recurrence-free survival
Factor
Hazard ratio
95%CI
P value
Primary tumor site0.0878
Gastric1.000--
Non-gastric2.6410.866-8.053-
Tumor size (cm)0.4749
≤ 2.01.000--
2.1-5.01.3180.006-292.7200.9201
5.1-10.01.6120.006-445.8880.8678
> 10.04.7650.015-1515.9610.5953
Mitotic index (/50 HPFs)0.03651
≤ 51.000--
6-101.8960.518-6.9490.3341
>106.7911.554-29.6720.01091
Tumor rupture 0.5202
No1.000--
Yes0.5890.117-2.957-
NIH risk classification 0.9763
Very low risk1.000--
Low risk0.2830.001-64.7790.6491
Intermediate risk0.2820.001-91.5150.6681
High risk0.2770.001-101.5080.6702
NLR0.7613
< 4.341.000--
≥ 4.340.8380.268-2.620-
PLR0.6958
< 220.761.000--
≥ 220.761.2590.397-3.995-
OPNI0.04141
≥ 51.301.000--
< 51.305.8521.072-31.964-